Andy Bosyi
Feb 18, 2014

Novartis Criticizes India Patent Landscape

Looks like Novartis is joining in on the controversy surrounding the Global IP Center's IP Ranking Report with regards to India's treatment of pharmaceutical patents.

Novartis puts pressure on India over patent abuse - FT.com
Novartis has urged US and European governments to “apply pressure” on India to respect intellectual property and warned New Delhi that its stance on patents is deterring investment. Joe Jimenez, chief executive of the Swiss drugmaker, urged India to